Jennifer FuCarneyMDMCR

Oncology • Honolulu, HI

Chief/Dept Hematology Oncology

Join to view full profile

Dr. Carney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Carney's full profile

Already have an account?

Office
3288 Moanalua Rd
Hawaii Permanente Medical Group
Honolulu, HI 96819
Phone+1 808-432-8587

Fax+1 808-432-8590

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2000 - 2003
University of North Carolina HospitalsResidency, Internal Medicine, 1997 - 2000
University of North Carolina at Chapel Hill School of MedicineClass of 1996

Certifications & Licensure

HI State Medical License 2003 - 2026
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Start of enrollment: 2012 Oct 03
Terminated
Phase 3
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
Completed
Phase 3
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
Completed
Phase 3
A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer Start of enrollment: 2014 May 01
Completed
Phase 2
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer Start of enrollment: 2022 Mar 07
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Ca...
Mariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi
Journal of Clinical Oncology. 2024-09-01
4 citations
Emerging bone health issues in women with breast cancer in Hawai'i.
Jennifer Fu Carney, James Davis
Hawaii Medical Journal. 2007-06-01